Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs
Open Access
- 5 July 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (13) , 7229
Abstract
β-thalassaemia is a rare genetic condition caused by mutations in the β-globin gene that result in severe iron-loading anaemia, maintained by a detrimental state of ineffective erythropoiesis (IE). The role of multiple mechanisms involved in the pathophysiology of the disease has been recently unravelled. The unbalanced production of α-globin is a major source of oxidative stress and membrane damage in red blood cells (RBC). In addition, IE is tightly linked to iron metabolism dysregulation, and the relevance of new players of this pathway, i.e., hepcidin, erythroferrone, matriptase-2, among others, has emerged. Advances have been made in understanding the balance between proliferation and maturation of erythroid precursors and the role of specific factors in this process, such as members of the TGF-β superfamily, and their downstream effectors, or the transcription factor GATA1. The increasing understanding of IE allowed for the development of a broad set of potential therapeutic options beyond the current standard of care. Many candidates of disease-modifying drugs are currently under clinical investigation, targeting the regulation of iron metabolism, the production of foetal haemoglobin, the maturation process, or the energetic balance and membrane stability of RBC. Overall, they provide tools and evidence for multiple and synergistic approaches that are effectively moving clinical research in β-thalassaemia from bench to bedside.Keywords
This publication has 113 references indexed in Scilit:
- Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in miceJournal of Clinical Investigation, 2013
- Oxidative Stress and-Thalassemic Erythroid Cells behind the Molecular DefectOxidative Medicine and Cellular Longevity, 2013
- Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemiaBlood, 2012
- Stress erythropoiesis: new signals and new stress progenitor cellsCurrent Opinion in Hematology, 2011
- Growth differentiation factor 15 in erythroid health and diseaseCurrent Opinion in Hematology, 2010
- Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesisProceedings of the National Academy of Sciences, 2009
- Erythroblastic islands: niches for erythropoiesisBlood, 2008
- Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemiaBlood, 2008
- Regulation of protein synthesis by the heme-regulated eIF2α kinase: relevance to anemiasBlood, 2006
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003